LILRB4 and Alzheimer disease: Given the previous studies for ITGAM/CD11b, LAPTM5 and LILRB4, it is tempting to speculate that they are involved in phagocytic processes involving synapses which are known to be reactivated during Alzheimer’s disease progression.